Revised MRPs of 1,364 anti-cancer formulations come into effect | PYQKosh Current

9 November 2026 · Economy

Good to Know· SSCGood to Know· UPSC

Revised MRPs of 1,364 anti-cancer formulations come into effect

Revised Maximum Retail Prices for 1,364 anti-cancer formulations came into effect, providing consumers an estimated annual saving of ₹3,540.38 crore. The price reduction follows the National Pharmaceutical Pricing Authority capping trade margins on the MRP of 137 anti-cancer drugs based on recommendations from an expert panel under the Directorate General of Health Services. Over 50 percent price cuts were recorded for 679 brands, with the highest price reduction reaching 96.45 percent across the regulated formulations.

Facts to remember

  1. 1Revised maximum retail prices for 1,364 anti-cancer formulations came into effect, projected to save consumers an estimated ₹3,540.38 crore annually.
  2. 2The National Pharmaceutical Pricing Authority capped trade margins on the maximum retail price of 137 anti-cancer drugs based on expert committee recommendations.
  3. 3Price reductions of over 50 percent were reported for 679 brands, with the highest price reduction recorded at 96.45 percent.

Test yourself

Q1.How much annual savings for consumers are projected following the enforcement of revised MRPs on anti-cancer formulations?

Q2.Which regulatory authority capped trade margins on the maximum retail price of the selected anti-cancer drugs?

Q3.What was the highest price cut percentage recorded among the revised anti-cancer drug formulations?

Sources: DD News: National · PIB (English)

Share this story

Revised MRPs of 1,364 anti-cancer formulations come into effectShare on WhatsApp